[Target cimetidine treatment of peptic ulcer. Considerations and assessment of a new dosage].
32 patients suffering from peptic ulcer have been selected. Of these 12 formed part of a previous series treated with cimetidine and subsequently relapsed; the other 20 were selected on the basis of endoscopic and functional examinations and were treated for the first time with cimetidine. The drug doses used were 1.2 g for 30 days and 0.3 g for a further 60 days. The purpose of the study was to check for possible recurrences by comparing the results obtained and their maintenance in the long term using these doses. 2 months after suspension of maintenance treatment there has not been any recurrence of the acute pain and dyspeptic symptomatology.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D002927:Cimetidine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy; D005260:Female; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*; D013276:Stomach Ulcer / Q000188:drug therapy
D006146:Guanidines; D002927:Cimetidine
Terapia cimetidinica mirata dell'ulcera peptica. Considerazioni e valutazioni su un nuovo dosaggio.